Related Experiment Video
Updated: Jul 8, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Clinical management of EGFRI dermatologic toxicities: the European perspective
Siegfried Segaert1, Eric Van Cutsem
1Department of Dermatology, Leuven University Hospital, Leuven, Belgium. siegfried.segaert@med.kuleuven.be
Abstract:
Dermatologic treatment of epidermal growth factor receptor inhibitor (EGFRI) skin toxicity is supportive and aims at maintaining quality of life while continuing EGFRI therapy. Despite the lack of randomized controlled trials or evidence-based guidelines, most cases of acneiform eruption are well controlled by topical metronidazole and oral minocycline 100 mg qd. For severe reactions, the minocycline dose is doubled and saline compresses are used. For superinfection with Staphylococcus aureus, oral cefuroxime axetil can be added for a short term. Emollients and topical steroids can be administered for skin dryness or eczema. Paronychia is the hardest to treat but antiseptic soaks and a corticosteroid paste can alleviate symptoms to some degree.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Drug Toxicity: Allergic Reactions
Nephrotic Syndrome III : Nursing Management
Mitogens and the Cell Cycle
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...